SCHEMBL6017485

SCHEMBL6017485

CCNC(=O)C1CCN(CCCCCC(=O)N(C)CCOC(=O)N(c2ccccc2-c2ccccc2)N2CC[CH]CC2)CC1

nearest known ligand 0.37

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CHRM3 P20309 9/20 0.37
HRH3 Q9Y5N1 1/20 0.37
CCR8 P51685 1/20 0.37
ALDH1A1 P00352 3/20 0.37
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
MAPK1 P28482 1/20 0.37
HTR1A P08908 1/20 0.36
DRD2 P14416 1/20 0.36
HTR7 P34969 1/20 0.36
HTR6 P50406 1/20 0.36
KCNH2 Q12809 1/20 0.36
LTA4H P09960 1/20 0.36
SLC2A1 P11166 2/20 0.35
POLB P06746 2/20 0.35
KDM4E B2RXH2 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6017536 0.91 HTR1A (0.36) CHRM3ALDH1A1MEN1KMT2AMAPK1
SCHEMBL6017445 0.85 CHRM2 (0.39) CHRM3ALDH1A1MEN1KMT2AMAPK1
SCHEMBL6016864 0.81 BCHE (0.37) ALDH1A1HTR1ADRD2HTR7HTR6
SCHEMBL2639275 0.78 CHRM2 (0.45) CHRM3ALDH1A1MEN1KMT2AKCNH2
SCHEMBL6028157 0.77 ACHE (0.39) CHRM3ALDH1A1HTR1ADRD2HTR7
SCHEMBL6017518 0.77 HTR1A (0.37) CHRM3ALDH1A1MEN1KMT2AMAPK1
SCHEMBL1361966 0.75 CHRM3 (0.65) CHRM3SLC2A1
SCHEMBL4691377 0.74 KMT2A (0.36) ALDH1A1KMT2AHTR1ADRD2HTR7
SCHEMBL6021912 0.74 CHRM2 (0.56) ALDH1A1KDM4E
SCHEMBL5247371 0.71 HTR3A (0.44) ALDH1A1MEN1KMT2AHTR1ADRD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1723112-A1 BIPHENYL COMPOUNDS USEFUL AS MUSCARINIC RECEPTOR ANTAGONISTS Theravance, Inc. (US) 2006-11-22 EP disclosed
WO-2005087736-A1 BIPHENYL COMPOUNDS USEFUL AS MUSCARINIC RECEPTOR ANTAGONISTS THERAVANCE, INC. (US) 2005-09-22 WO disclosed